Unravelling mechanisms of p53-mediated tumour suppression. - Wikidata - awgldk - TriplyDB

Unravelling mechanisms of p53-mediated tumour suppression.

Unravelling mechanisms of p53-mediated tumour suppression.

http://www.wikidata.org/entity/Q38205099

about

Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways Chemical Variations on the p53 Reactivation Theme Mechanisms of ferroptosis Targeting of Mutant p53 and the Cellular Redox Balance by APR-246 as a Strategy for Efficient Cancer Therapy Targeted drugs in small-cell lung cancer MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer The mutational landscape of hepatocellular carcinoma Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors Cullin family proteins and tumorigenesis: genetic association and molecular mechanisms NOD-Like Receptors: Master Regulators of Inflammation and Cancer Undercover: gene control by metabolites and metabolic enzymes Caveolin-1 in the regulation of cell metabolism: a cancer perspective Chemoresistance and targeted therapies in ovarian and endometrial cancers Reprogramming of germ cells into pluripotency P53-MDM2 Pathway: Evidences for A New Targeted Therapeutic Approach in B-Acute Lymphoblastic Leukemia Regulation of p53 by Mdm2 E3 ligase function is dispensable in embryogenesis and development, but essential in response to DNA damage The tumour suppressor CYLD regulates the p53 DNA damage response Epidemiology of basal cell carcinoma: scholarly review.Cluster Analysis of p53 Binding Site Sequences Reveals Subsets with Different Functions.Structural visualization of the p53/RNA polymerase II assembly.GOLPH3 drives cell migration by promoting Golgi reorientation and directional trafficking to the leading edge.Cancer: A piece of the p53 puzzle.Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation.Dissect the Dynamic Molecular Circuits of Cell Cycle Control through Network Evolution Model.Essential role for centromeric factors following p53 loss and oncogenic transformation Oral Administration of Tualang and Manuka Honeys Modulates Breast Cancer Progression in Sprague-Dawley Rats Model.Hepatitis C Virus Indirectly Disrupts DNA Damage-Induced p53 Responses by Activating Protein Kinase R.Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy Argininosuccinate synthase 1 is an intrinsic Akt repressor transactivated by p53 The role of MDM2 and MDM4 in breast cancer development and prevention.Discovery of Mieap-regulated mitochondrial quality control as a new function of tumor suppressor p53 Lipidomic analysis of skeletal muscle tissues of p53 knockout mice by nUPLC-ESI-MS/MS.The Effect of Sodium Valproate on the Glioblastoma U87 Cell Line Tumor Development on the Chicken Embryo Chorioallantoic Membrane and on EZH2 and p53 Expression.Nucleolin and nucleophosmin: nucleolar proteins with multiple functions in DNA repair.Roles of tumor suppressors in regulating tumor-associated inflammation.The p53 isoform Δ133p53β promotes cancer stem cell potential.TP53 engagement with the genome occurs in distinct local chromatin environments via pioneer factor activity Mechanism of initiation of aggregation of p53 revealed by Φ-value analysis Analysis of p53 transactivation domain mutants reveals Acad11 as a metabolic target important for p53 pro-survival function.Evaluation of sgRNA target sites for CRISPR-mediated repression of TP53

P2860

Q26742114-DCC65559-1573-4668-A6B7-17692FA51019 Q26749008-E793DA65-6E54-48F4-9956-474CBC456200 Q26751418-42260CC4-F653-4970-81DA-2DED559876E5 Q26766341-4444B525-363E-4825-9A50-372E3D0B6FB2 Q26767017-4DF9F75A-1C87-41A7-8BC8-54C8BF41E287 Q26775610-C911F9FB-A72F-4EE8-A706-72A53B6E181E Q26777478-11ED6A45-32E6-4474-B83E-53FBD8C8E7E5 Q26783710-96FCB5E6-347E-437E-80D3-826D16858C13 Q26822657-5E9F7BF8-DA97-424E-A4FE-66D110530118 Q26865199-E53D692B-9513-480F-BB06-042FEE03B7FD Q28072281-4C038BE8-021E-4CD5-8F61-F9EF282C5B66 Q28072525-47B724C0-5669-4711-BBB6-65A332865979 Q28073246-5B1C15DC-6928-4DF0-8BB3-36C940F1A6B9 Q28078353-73CC5EAA-E7EC-4740-94F4-64F82E9A6AAE Q28078609-E54B98E2-ECCC-4EA5-BCBD-901502816568 Q28510160-A7B97E12-E8ED-4D2A-8415-9BCE05A32E8F Q28828272-81B2088E-18AB-4BEA-97BF-5BEF30A7D42E Q30235834-A432728F-F75A-4863-91B0-8883493B3BC1 Q30394872-ED943434-C426-4CEA-8F94-373E02F0442B Q30832097-8B1481B9-7B48-40F4-91A9-5D85439FB0BD Q30832460-7AD3E728-2851-4BF4-9CF8-F59AE4FCF88D Q33360347-46D14359-FB37-431B-8EE2-09E72047C34B Q33420276-33308A56-E618-410A-B90B-265E42F1D540 Q33561346-D618CDD5-0B42-4732-90B1-31D056621F99 Q33568800-2E82642A-3B16-4C7D-88D5-4B1B1E41D9E5 Q33578733-D27813ED-700E-4549-ABFF-BD86DEEAE311 Q33603822-EC8366FA-E7C3-4828-9811-4AAC7E063F1A Q33633277-F1E57437-E969-4374-9E7F-B08B1E63062B Q33708112-75A4A10B-F368-4566-9462-8536150342CB Q33712095-45FA8F99-5CC3-4F17-B05B-273673A7013C Q33738750-FAA8804B-755D-4847-951D-284463B74D95 Q33789472-480B02AF-451E-4AC9-AF9C-052058630088 Q33794860-FC2526CD-B02F-403A-B53E-A94F27F8DE6B Q34047444-CCD4455C-A9D7-499E-B1EA-25ABD852E166 Q34413441-94CFE088-1D89-4472-A136-F39223E3A377 Q34466356-6C120143-B97C-48C3-B767-52F1DE26A628 Q35042948-B7B172A6-26C1-48FD-9147-43116B64671B Q35134797-C65EC62F-B6CD-4988-9B8A-3B4598AA1D81 Q35195372-5DC7207B-69CA-4B50-9CE2-CBE73B552F44 Q35421685-DDBA415C-2CB9-4D99-B2C2-3E3848392BD2

P2860

Unravelling mechanisms of p53-mediated tumour suppression.

http://www.wikidata.org/entity/Q38205099

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Unravelling mechanisms of p53-mediated tumour suppression.

@en

type

label

Unravelling mechanisms of p53-mediated tumour suppression.

@en

prefLabel

Unravelling mechanisms of p53-mediated tumour suppression.

@en

P1433

Q38205099-96021550-F26B-488E-A2D7-E131A24C5596

P1476

Q38205099-73D09AB9-DD26-40C3-B8FF-E60C882C525B

P2093

Q38205099-3A7BCA8A-E1A6-4EA1-9A12-B48FB9245EE2

Q38205099-C1C8100E-5447-4B3F-9A11-AAD1710DBEAE

P2860

Q38205099-014E6BFA-88A8-4C11-8769-77C8CDC6F63E

Q38205099-01711D5A-3989-459E-986F-3ADB9A6BC73D

Q38205099-0406A2E8-9771-4CF3-9787-4DAE89C68002

Q38205099-04ECD953-2375-4F3B-84AC-F9CFFAACB33B

Q38205099-05033743-1B85-4C24-9F6D-477931F5201B

Q38205099-051483C7-7548-40D1-AE11-5CE2F52F8E66

Q38205099-06C79C78-2DD0-481B-A7FD-B85E43FCB25D

Q38205099-086063CB-72DE-4894-80BE-989300C6809A

Q38205099-091FA475-D072-4EDD-A574-6BDB64221E26

Q38205099-0A29E362-403A-4188-AAC0-3F331E1A5E07

P2888

Q38205099-8140FF62-D1B2-42FC-AE69-9CF579A10527

P304

Q38205099-9A6F8756-3537-4495-BCC2-C1EFF4560058

P31

Q38205099-40F8E439-E52F-4E4F-8E0A-0264F8AE39F9

P356

Q38205099-86A22B8C-40CF-4A1E-BE49-5C76098CCE6B

P407

Q38205099-CF253370-298B-4605-AF60-2C418B88D42B

P433

Q38205099-3A5E25C4-101C-4CE7-8A13-BDF8662F98B7

P478

Q38205099-E20CDA71-D65C-4D8A-AD1F-138EA8F6243E

P50

Q38205099-996939FB-A560-4E69-B9DC-AACB3C59B805

P577

Q38205099-F2D51763-9AF5-4218-84EC-CC4AC37B17F9

P6179

Q38205099-64E4A18E-DBB6-4B3A-BA2D-FADF097A8AED

P698

Q38205099-6E3967F4-67BC-40E2-81AF-041737B898F1

P932

Q38205099-6E4D5633-8E9F-4DE0-BB2D-E098CCC9E994

P356

P1433

Nature Reviews Cancer

P1476

Unravelling mechanisms of p53-mediated tumour suppression.

@en

P2093

Kathryn T Bieging

http://www.w3.org/2001/XMLSchema#string

Laura D Attardi

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53

Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation

Modulation of the vitamin D3 response by cancer-associated mutant p53

Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function

Mdm2 promotes the rapid degradation of p53

Ku86 autoantigen related protein-1 transcription initiates from a CpG island and is induced by p53 through a nearby p53 response element

Suppression of tumorigenesis by the p53 target PUMA

The DNA-damage response in human biology and disease

Direct cell reprogramming is a stochastic process amenable to acceleration

Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases

P2888

P304

359-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRC3711

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Stephano S. Mello

P577

2014-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1017816077

http://www.w3.org/2001/XMLSchema#string

P698

24739573

http://www.w3.org/2001/XMLSchema#string

P932

4049238

http://www.w3.org/2001/XMLSchema#string